Cargando…

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

BACKGROUND: Lung immune prognostic index (LIPI) is a prognostic marker of extensive-stage small cell lung cancer (ES-SCLC) patients received immunotherapy or chemotherapy. However, its ability in limited-stage SCLC (LS-SCLC) should be evaluated extensively. METHODS: We retrospectively enrolled 497 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Bochen, Hou, Qing, Liang, Yu, Xue, Shuqin, Yao, Ningning, Wei, Lijuan, Cao, Xin, Li, Hongwei, Si, Hongwei, Cao, Jianzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706962/ https://www.ncbi.nlm.nih.gov/pubmed/36447193 http://dx.doi.org/10.1186/s12885-022-10351-7

Ejemplares similares

External Application of a Nomogram to Predict Survival and Benefit of Peripheral Blood Inflammatory Indexes in Limited-Stage Small Cell Lung Cancer
por: Wei, Lijuan, et al.
Publicado: (2022)

Construction of Brain Metastasis Prediction Model and Optimization of Prophylactic Cranial Irradiation Selection for Limited-Stage Small-Cell Lung Cancer
por: Hou, Qing, et al.
Publicado: (2022)

Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type
por: Yao, Ningning, et al.
Publicado: (2020)

Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram
por: Cao, Jianzhong, et al.
Publicado: (2017)

The Clinical Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Brain Metastases from Non–Small Cell Lung Cancer-Harboring EGFR Mutations
por: Li, Hongwei, et al.
Publicado: (2020)

Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer
por: Sonehara, Kei, et al.
Publicado: (2020)

Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases
por: Li, Hongwei, et al.
Publicado: (2017)

The prognostic value of osteopontin in limited-stage small cell lung cancer patients and its mechanism
por: Liu, Fanglei, et al.
Publicado: (2017)

Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients
por: Zeng, Qingpeng, et al.
Publicado: (2021)

Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib
por: Liu, Jingjing, et al.
Publicado: (2020)

Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer
por: Liu, Jun, et al.
Publicado: (2022)

Highlight report: Limits of prognostication of non-small cell lung cancer
por: Adawy, Alshaimaa
Publicado: (2017)

Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients
por: Liu, Di-Han, et al.
Publicado: (2019)

The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
por: Aldea, Mihaela, et al.
Publicado: (2020)

Prognostic value of cancer antigen -125 for lung adenocarcinoma patients with brain metastasis: A random survival forest prognostic model
por: Wang, Hao, et al.
Publicado: (2018)

Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status
por: Li, Hongwei, et al.
Publicado: (2017)

Prognostic Value of the Lung Immune Prognostic Index for Metastatic Non-Small Cell Lung Cancer Patients: A Chinese Cohort Study
por: Huang, Jing, et al.
Publicado: (2023)

Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
por: Tanaka, Satomi, et al.
Publicado: (2022)

Prognostic significance of modified lung immune prognostic index in osteosarcoma patients
por: He, Xuanhong, et al.
Publicado: (2022)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer
por: Kumagai, Shogo, et al.
Publicado: (2017)

Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists
por: Xu, Chang, et al.
Publicado: (2022)

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer
por: Zhao, Ziran, et al.
Publicado: (2023)

Prognostic Factors in Stage III Non-Small-Cell Lung Cancer Patients
por: Urvay, Semiha Elmaci, et al.
Publicado: (2016)

Advanced Lung Cancer Inflammation Index is a Prognostic Factor of Patients with Small-Cell Lung Cancer Following Surgical Resection
por: Hu, Zhonghui, et al.
Publicado: (2021)

The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer
por: Peng, Si-Min, et al.
Publicado: (2022)

Characteristics and prognostic factors for pain management in 152 patients with lung cancer
por: Shi, Lei, et al.
Publicado: (2016)

Role of prognostic nutritional index in postoperative radiotherapy for non‐small cell lung cancer
por: Ryu, Hyejo, et al.
Publicado: (2023)

Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancer
por: Fu, Fangqiu, et al.
Publicado: (2021)

Prognostic Factors in Stage IIB Non-Small Cell Lung Cancer according to the 8th Edition of TNM Staging System
por: Shin, Jin Won, et al.
Publicado: (2019)

Prediction of Clinical Outcome for All Stages and Multiple Cell Types of Non-small Cell Lung Cancer in Five Countries Using Lung Cancer Prognostic Index()
por: Chen, Tiehua, et al.
Publicado: (2014)

Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis
por: Zhang, Jianguo, et al.
Publicado: (2020)

Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer
por: Lee, Joohwan, et al.
Publicado: (2015)

Comprehensive analysis of prognostic predictors for patients with limited-stage small-cell lung cancer who underwent resection followed by adjuvant chemotherapy
por: Feng, Jian, et al.
Publicado: (2021)

Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients
por: Liu, Tingting, et al.
Publicado: (2021)

A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy
por: Cao, Jianzhong, et al.
Publicado: (2016)

Surgery for limited stage small cell lung cancer
por: Gergen, Anna K., et al.
Publicado: (2020)

Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
por: Minami, Seigo, et al.
Publicado: (2017)

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
por: Boldrini, L, et al.
Publicado: (2005)

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_470077gfkicgjjvvhhncmaru6o